Reference6 articles.
1. 1. LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Tigecycline. National Institute of Diabetes and Digestive and Kidney Diseases; 2012. Updated January 23, 2019. https://www.ncbi.nlm.nih.gov/books/NBK547888
2. 2. Robinson MJ, Rywlin AM. Tetracycline-associated fatty liver in the male. Report of an autopsied case. Am J Dig Dis. 1970;15(9):857-862. doi:10.1007/BF02236049
3. 3. Patel V, Sanyal AJ. Drug-induced steatohepatitis. Clin Liver Dis. 2013;17(4):533-546, vii. doi:10.1016/j.cld.2013.07.012
4. 4. Choi YJ, Lee CH, Lee KY, Jung SH, Lee BH. Increased hepatic fatty acid uptake and esterification contribute to tetracycline-induced steatosis in mice. Toxicol Sci. 2015;145(2):273-282. doi:10.1093/toxsci/kfv049
5. 5. Shi X, Lao D, Xu Q, Li X, Lv Q. A case report of drug-induced liver injury after tigecycline administration: histopathological evidence and a probable causality grading as assessed by the updated RUCAM diagnostic scale. BMC Infect Dis. 2022;22(1):368. doi:10.1186/s12879-022-07258-w
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tigecycline;Reactions Weekly;2024-06-08